SB 5594
By resolution, returned to Senate Rules Committee for thi…
Concerning biosimilar medicines.
- Washington
- Senate
- Introduced Jan 30, 2025
- Session 2025-2026
Official Bill Page
Loading official bill page…
This state’s bills aren’t available here
Washington’s legislature doesn’t allow its bill pages to be shown on other sites. You can read the full bill on the official page.
View on official siteLegislative Timeline
28 actions-
By resolution, returned to Senate Rules Committee for third reading.
-
Referred to Rules 2 Review.
-
HCW - Majority; do pass.
-
Executive action taken in the House Committee on Health Care & Wellness at 1:30 PM.
-
Public hearing in the House Committee on Health Care & Wellness at 8:30 AM.
-
First reading, referred to Health Care & Wellness.
-
Third reading, passed; yeas, 49; nays, 0; absent, 0; excused, 0.
-
Rules suspended. Placed on Third Reading.
-
Floor amendment(s) adopted.
-
Returned to second reading for amendment.
-
Rules suspended.
-
Placed on third reading.
-
Rules Committee relieved of further consideration.
-
By resolution, reintroduced and retained in present status.
-
By resolution, returned to Senate Rules Committee for third reading.
-
Executive session scheduled, but no action was taken in the House Committee on Health Care & Wellness at 1:30 PM.
-
Public hearing in the House Committee on Health Care & Wellness at 1:30 PM.
-
First reading, referred to Health Care & Wellness.
-
Third reading, passed; yeas, 49; nays, 0; absent, 0; excused, 0.
-
Rules suspended. Placed on Third Reading.
-
Floor amendment(s) adopted.
-
1st substitute bill substituted (HLTC 25).
-
Placed on second reading by Rules Committee.
-
Passed to Rules Committee for second reading.
-
HLTC - Majority; 1st substitute bill be substituted, do pass.
-
Executive action taken in the Senate Committee on Health & Long-Term Care at 10:30 AM.
-
Public hearing in the Senate Committee on Health & Long-Term Care at 10:30 AM.
-
First reading, referred to Health & Long-Term Care.